secwatch.observer — SEC 8-K summary
======================================

Issuer:     Strata Critical Medical, Inc. (SRTA)
CIK:        0001779128
Form:       8-K
Filed at:   2025-11-10T23:59:59+00:00
Accession:  0001628280-25-050785
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Strata Critical Medical Q3 revenue up 36.7% to $49.3M; net loss widens to $9.7M
-------------------------------------------------------------------------------

- Revenue $49.3M, up 36.7% YoY; organic growth 29.0% excluding Keystone acquisition.
- Net loss from continuing ops $(9.7)M, widened from $(5.6)M in prior-year period.
- Medical Segment Adjusted EBITDA $7.6M, +93.5% YoY; margin 15.3% (up 450 bps).
- Raised FY2025 revenue guidance to $185-195M; reaffirmed Adjusted EBITDA range.
- Investor Day on Nov 17, 2025 to introduce FY2026 guidance and medium-term targets.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1779128/000162828025050785/0001628280-25-050785-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1779128/000162828025050785/srta-20251110.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-050785

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer